Facial Contouring / Full-Face Filler

What is facial contouring / full-face filler?

Facial contouring, or full-face filler, is a method in which hyaluronic acid filler is used in several areas of the face; the areas are planned together, according to how they relate to each other, rather than one by one. ‘Full face’ simply means the whole face. The medical term is ‘panfacial’, meaning assessment and treatment that cover the whole face. The name describes a way of planning, not a product or a proprietary technique.

The reasoning behind this approach is that the overall appearance of the face is determined by its proportions and contours, and the shape of the mid-face and lower face also affects how the whole face is perceived. The approach recommended in scientific publications has likewise shifted from treating individual areas to assessing the face as a whole. Because the cheekbones and chin influence the contour of the rest of the face, they are treated as starting points in these plans.

A joint recommendation from a group of experts in dermatology, surgery around the eyes (oculoplastic surgery) and plastic surgery points the same way: a whole-face assessment should cover the person’s psychological and cultural characteristics as well as the anatomical findings, and the consultation should be person-centred and follow a set structure.

The substance used in this treatment is hyaluronic acid. According to scientific reviews of facial fillers, hyaluronic acid fillers provide volume immediately, are reversible and are considered the first choice for many uses. When the clinic assesses a product, approval by the US Food and Drug Administration (FDA) is not the sole criterion; the assessment is based on the product’s CE marking, its registration and conformity status in Türkiye, and the manufacturer’s intended purpose.

RELATEDWhat Is Hyaluronic Acid?

SOURCEPMID 39372878PMID 41325038PMID 42479576

How is the face assessed as a whole?

A whole-face assessment does not focus on a single line or hollow; it considers the layers of the face and the balance between its areas together. Scientific publications look at facial ageing ‘from the inside out’: the bony structure remodels, the fat compartments (fat pads) lose volume or shift, muscle tension (tone) and thickness change, and the skin becomes thinner and weaker. Each of these changes takes place in a separate layer.

Looking at ageing separately in the upper, middle and lower thirds of the face can help decide what to prioritise in treatment and explain the reasoning behind that decision. In practice, this means that the same concern can come from a different layer in different people, and a volumising filler targets only one of these layers.

Photo-based grading scales have been developed to make assessment more consistent. A series of scales developed for jawline contour, temple volume, receding chin, nasolabial folds (the lines running from the side of the nose to the corners of the mouth) and mid-face volume loss has been reported to show a high level of consistency when used by trained assessors. These scales give doctors a common language; however, they are not a threshold that decides on its own whether you are suitable for a treatment.

According to the joint recommendation of an international expert group, a natural result should be defined not only by appearance but also by touch, feel and facial expression. Safety is the foundation, and the plan should be tailored to the individual. The principle is short: treat the person, not the photograph.

SOURCEPMID 33325497PMID 35350387PMID 41794404

The mid-face and cheekbone area

In whole-face plans, the mid-face is often the first area to be assessed. Because treatment of the cheekbone area clearly affects the contour of the whole face, this area is treated as an ‘anchor’, that is, a starting point, in whole-face treatment. Age-related changes in the cheekbones and chin can unintentionally give the face a tired, angry or sad expression.

Hyaluronic acid fillers are used to replace lost volume in the mid-face, chin and jawline and to soften sharp transitions that become more noticeable with age. An analysis combining the results of many studies (a meta-analysis) defined the mid-face as the area covering the front inner part of the cheek, the area around the cheekbone and the area below the cheekbone. This analysis reported that the frequency of swelling, lumps and firmness in the nasolabial fold area was significantly different from that in the other areas (the mid-face, the area around the lips, and the lips).

The mid-face is also an area where a gap is seen between perceived and measured results. In a study of 101 female patients who had hyaluronic acid injected into four areas of the face and were followed with three-dimensional imaging and patient questionnaires, the improvement that patients perceived continued even though the measured volume in the cheekbone area decreased. According to the researchers, this finding can guide the discussion between patient and doctor about how often the treatment should be repeated. This suggests that a measured decrease in volume should not, on its own, be considered a reason for a new treatment.

RELATEDCheek Filler

SOURCEPMID 39372878PMID 37261136PMID 41978570

The chin, jawline and lower face

In the lower face, the chin and jawline are treated as the second anchor of the whole-face plan. Like the cheekbones, the chin has a strong effect on the contour and definition of the face; for this reason, it is considered one of the starting points in whole-face treatment. In planning, the recommendation is to focus on the relationship between the mid-face and the lower face.

The contour of the lower face can be addressed not only by adding volume but also, where appropriate, in combination with methods that reduce volume. In other words, a whole-face plan does not mean ‘filler in every area’. In some areas, what is missing is volume; in others, there is excess volume or muscle bulk, and in these cases filler may not be the answer.

The layer-by-layer changes of facial ageing also affect the lower face: remodelling of the bony structure, changes in the fat pads, changes in muscle tension and thinning of the skin are reflected in the appearance of this area too. You can find details specific to the chin and jawline, the blood vessels in this area and the limits of the treatment on the Chin and Jawline Filler page; here, the lower face is discussed only as part of the overall plan.

RELATEDChin and Jawline Filler

SOURCEPMID 39372878PMID 33325497

Why is the total amount a separate question?

When several areas are treated, one of the questions to discuss is how much filler the face receives in total and how this builds up over time. Hyaluronic acid fillers are considered temporary products that the body breaks down over time. According to an assessment by an international expert group, the clinical effect usually lasts 4–18 months; this depends on the product, the technique and the person.

A fading effect may not mean that the gel has completely left the tissue. In a study that reviewed magnetic resonance imaging (MRI) scans of 33 patients who had hyaluronic acid injected into the mid-face, the filler was still detected in all patients at least two years after treatment; in one patient, it was reported to have remained for up to 15 years. Nine of these patients had been scanned because of swelling. The study is small, and the researchers state that follow-up in larger groups is needed.

Volume may not always decrease as expected either. In a study that used three-dimensional MRI to examine 14 patients with recorded previous filler treatments, the measured filler volume clearly exceeded the recorded injected volume, at a reported ratio of 1:2.8. The researchers stress that some hyaluronic acid fillers may expand rather than decrease after treatment, and that this should be taken into account in planning. This study is small and looks at only one point in time (a cross-sectional study); its results cannot be generalised.

The relationship between amount and effect is not linear either. A review that critically examined measurements of the ‘lifting’ effect of fillers notes that, in studies looking at the relationship between dose and effect, the measured displacement did not increase steadily as the injected volume increased. For this reason, no general figure is given for the total amount; the amount is assessed at your consultation, together with your previous treatments.

SOURCEPMID 42499804PMID 39015357PMID 42396227PMID 42620772

An overfilled look

In medical terms, an overfilled look is called ‘facial overfilled syndrome’, and it is attributed to excessive or inappropriate use of fillers. In this condition, the face looks distorted at rest and facial movements lose their natural quality. It is often accompanied by considerable psychological distress.

The problem does not come from excess volume alone. Placement that does not fit the anatomy, disruption of the tissue’s mechanical structure and the load that builds up over time from repeated treatments all play a part. The recommendation in this field is to move from simply replacing volume to precise treatment specific to each layer. Reducing the risk is based on informing the patient and on knowledge of anatomy.

Researchers who have studied the causes of overfilling group them into three categories. The first group is technical factors: an inappropriate choice of dose, depth or injection point. The second group is patient-related factors: the pursuit of ‘perfect’ facial features and unrealistic expectations. The third group is practitioner-related factors: lack of experience and misinterpretation of aesthetic criteria. The recommended precautions include assessment and planning before treatment, informing the patient, layered injection and regular follow-up.

Studies of perception point the same way. In a study in which 263 people rated computer-altered images of faces from their own ethnic group, faces with several features altered together were rated as less attractive than unaltered faces. This was an experimental study using images, and it is not a criterion for an individual decision. According to expert opinion, the risk of overfilling does not come from the product itself; it is linked to insufficient knowledge of anatomy, inappropriate technique, or inappropriate patient selection and patient information.

SOURCEPMID 41948082PMID 40785833PMID 42169418PMID 42499804

Limits of this treatment

Whole-face filler provides volume and contour support. It does not lift sagging tissue back into place, it does not remove excess skin, and on its own it does not improve the quality of the skin itself. Treating several areas does not change this limit; the same limit simply applies to more than one area.

Scientific publications are cautious about sagging. According to a review that examined this question critically, the concept of ‘lifting’ often used for fillers has no agreed definition, no accepted measurement standard and no validated threshold for what counts as clinically meaningful. All published numerical measurements reflect changes at the skin surface; deeper structures have not been tracked separately. This does not mean that fillers have no lifting effect; however, this effect has not yet been defined with the precision that the claims made about it would require.

Skin quality is a separate layer. Thinning and weakening of the skin is a component of ageing that is separate from changes in bone and fat tissue. Types of filler also work in different ways: hyaluronic acid provides volume immediately, whereas calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA) and polycaprolactone (PCL) provide structural support by stimulating collagen production.

In practice, this means that if the main cause of the visible change is marked skin laxity (loose skin) or skin quality, a filler plan spread across the whole face may not meet your expectations; adding areas or more filler will not close this gap. In that case, another method, a combination of methods or a surgical option can be discussed. Having no treatment at all is also a valid option.

RELATEDCombined Facial Rejuvenation

SOURCEPMID 42620772PMID 33325497PMID 42479576

How it differs from a liquid facelift and combined facial rejuvenation

All three treatments can target several areas of the face; the difference lies in the method used and the way it works. Facial contouring is done with hyaluronic acid. A liquid facelift uses substances that stimulate collagen production. Combined facial rejuvenation brings several methods together within the same plan.

According to scientific reviews of facial fillers, hyaluronic acid fillers provide volume immediately and are reversible. Calcium hydroxylapatite, poly-L-lactic acid and polycaprolactone both add volume and stimulate collagen production; they are found useful where structural support and longer-lasting correction are needed. It is also emphasised that anatomy-based, layered injection techniques improve results and reduce complications.

In practice, the clearest difference is reversibility. The enzyme hyaluronidase can be used for most unwanted effects of hyaluronic acid filler. These are divided into non-urgent and urgent situations: a bluish discolouration under the skin (the Tyndall effect), non-inflammatory nodules (small firm lumps you can feel under the skin) and hypersensitivity reactions are non-urgent; vascular occlusion (a blocked blood vessel) and vision loss are emergencies. Collagen stimulators cannot be dissolved with an enzyme; you can find the details, with references, on the Liquid Facelift with Collagen Stimulators page.

Thread lifts are a separate family of methods and are described on their own pages, such as Facial Thread Lift; the approach in which methods are planned together is covered on the Combined Facial Rejuvenation page. Which method suits you, whether several should be used together, or whether none is suitable depends on which layer the visible change comes from. This distinction is made at your consultation.

RELATEDLiquid Facelift with Collagen Stimulators

SOURCEPMID 42479576PMID 38231537

Known risks

Facial contouring is a medical procedure, and each injection area has its own specific risks. Treating several areas means these risks are combined in a single plan. An analysis combining the results of studies of hyaluronic acid fillers in the face reported the following adverse effects: swelling, pain, redness, bruising, lumps, firmness, tenderness, itching and discolouration. For some of these, the frequency was found to differ from one area to another.

Delayed inflammatory reactions are rare, but they can appear months or even years later. In an analysis that pooled studies of facial treatments, the frequency of these reactions was calculated as about one event per 2,000 patients followed for one year. The time until symptoms began was a median of 3 months, with a shortest time of two weeks and a longest of 12 years. Common presentations are nodules, redness, swelling and hardening.

The most serious risk is filler entering an artery and blocking the blood supply to the tissue. This can lead to tissue damage, scarring, vision loss and stroke. Studies of risk factors for vascular occlusion have reported that the most frequently affected areas are those with complex blood vessel anatomy, such as the area between the brows, the nose and the nasolabial folds; they also state that recognising and treating the occlusion in time is associated with recovery. Consensus guidelines from UK experts also describe vision loss as a rare but serious complication; they recommend improving the process of informing patients and obtaining their agreement (consent), and raising awareness of this complication.

Studies of complications that led to permanent damage show that the injected volume is not the only deciding factor; the injection site, the technique and how permanent the filler is also play a decisive role. To reduce the risk of vascular occlusion with hyaluronic acid filler, the key points are injecting the filler in small amounts, using low pressure on the syringe plunger, and the practitioner’s knowledge and skill. It is also stressed that pulling back on the plunger to check (aspiration) does not reliably show that the needle tip is not inside a blood vessel. The doctor chooses a needle or a cannula individually for each person, according to the treatment area and the anatomy.

SOURCEPMID 37261136PMID 42781409PMID 40406769PMID 42087426PMID 41490283PMID 42298154

Can it be reversed, and what happens to previous fillers?

Hyaluronic acid filler can be dissolved with an enzyme called hyaluronidase; this is one of the main reasons hyaluronic acid is preferred in a whole-face plan. Scientific publications describe hyaluronidase as the preferred treatment for complications of hyaluronic acid filler. However, doses and treatment protocols are not standardised, and in many countries this use is off-label, that is, outside the uses covered by the product’s licence or approval (its label). Hyaluronidase is kept at the clinic.

Dissolving has its limits too. In a study that reviewed the records of 90 patients (157 eye areas) whose filler around the eyes had been dissolved with hyaluronidase, facial changes such as hollowing were reported in 18% of cases. These changes were significantly associated with the amount of filler in the tissue and how long it had been there. The researchers recommend that people with a long history of filler and a high total amount are informed about this risk. These findings relate to the eye area and cannot be directly generalised to the whole face.

Fillers you have had in the past are a separate matter. According to a review of permanent complications, hyaluronic acid continues to be preferred because it can be reversed, whereas permanent fillers increase the risk of complications in the long term. If you have had filler elsewhere, you will first be asked what type of filler it was, when it was done and which area was treated. Filler of unknown type, or filler that cannot be confirmed to be hyaluronic acid, is not dissolved straight away.

RELATEDFiller Dissolving

SOURCEPMID 38231537PMID 41517528PMID 38655103PMID 42298154

If a surgical facelift is considered in the future

How repeated whole-face filler affects a possible future surgical facelift has not yet been clearly answered. In a survey of members of an aesthetic surgery society in the US, about half of the participants reported that a history of repeated whole-face filler made facelift surgery more difficult. The most frequently mentioned problems were: filler that can be felt or seen, impaired blood supply to the layer of skin that is lifted and repositioned during surgery (the skin flap), and a lift that lasts for a shorter time. The survey response rate was 3.7%; the findings reflect surgeons’ observations, not measured outcomes.

There is also an observation pointing the other way. In a study that reviewed the records of 20 patients who had facelift surgery at a single institution and had previously had injectable treatments, no notable surgical complications attributed to previous filler or collagen stimulator treatments were reported. However, the researchers state that, because the group was small, no firm conclusion can be drawn about safety.

According to recommendations from an expert group, temporary fillers are considered relatively low risk; permanent fillers, and temporary fillers or threads placed recently, are among the higher-risk groups. The same recommendations include individual planning before surgery. The authors of the survey also recommend that the fillers used and any complications are recorded accurately and, if surgery is planned, discussed in detail before the operation.

SOURCEPMID 36860684PMID 41664552PMID 40852439